MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 216 filers reported holding MEDIVATION INC in Q4 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,680,000 | +1652.8% | 77,614 | +1303.0% | 0.27% | +1405.6% |
| Q4 2015 | $267,000 | -96.7% | 5,532 | -97.1% | 0.02% | -96.3% |
| Q3 2015 | $8,189,000 | -27.2% | 192,681 | +95.7% | 0.49% | -22.3% |
| Q2 2015 | $11,241,000 | +37.6% | 98,433 | +55.5% | 0.63% | +26.5% |
| Q1 2015 | $8,168,000 | +120.5% | 63,286 | +70.2% | 0.50% | +64.7% |
| Q4 2014 | $3,704,000 | -54.3% | 37,181 | -54.7% | 0.30% | -44.9% |
| Q3 2014 | $8,107,000 | +109.4% | 81,996 | +63.2% | 0.55% | +73.5% |
| Q2 2014 | $3,872,000 | +353.4% | 50,238 | +252.8% | 0.32% | +99.4% |
| Q3 2013 | $854,000 | – | 14,240 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |